Support WBURFDA-Approved Knock-Offs Of Biotech Drugs Could Safely Save Big BucksAlison KodjakAugust 01, 2016 ShareIn 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. (AFP/Getty Images)
